Frederick Hrkac - May 12, 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Role
Director
Signature
/s/ Frederick Hrkac
Stock symbol
BSGM
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
6/21/2022, 05:01 PM
Previous filing
Jun 21, 2022
Next filing
Nov 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSGM Stock Option (Right to Buy) Award $0 +50K $0.00 50K May 12, 2022 Common Stock 50K $0.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares underlying this stock option vested and became exercisable immediately on the date of grant and 50% will vest and become exercisable on the first anniversary of the date of the director appointment on April 28, 2022, provided Mr. Hrkac is still serving as a director on such date and subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan.